Company Profiles


Headquartered in Switzerland, Ferring Pharmaceuticals is a research-driven, specialty biopharmaceutical group active in global markets. The company identifies, develops and markets innovative products in the areas of reproductive health, urology, gastroenterology, endocrinology and orthopaedics. Ferring has its own operating subsidiaries in nearly 60 countries and markets its products in 110 countries. To learn more about Ferring or its products please visit

Merck KgaA
Frankfurter Str. 250 | Postcode: F131/112 | 64293 Darmstadt | Germany
+49 6151 72-0
+49 6151 72-2000

Merck, leader in fertility treatments, combines more than 60-year heritage of fertility expertise and a deep understanding with a visionary commitment to the future of fertility. The company's vision is to maximize success in ART for the benefit of patients by bringing innovative technologies and developing easy-to-use products and devices, as well as patient care support services, to help infertile couples at every stage of the reproductive cycle.
We will actively seek breakthrough innovation in drugs and beyond, including in diagnostic technologies and services which have the potential to improve the "take home baby rate”.

6343 Rotkreuz
Telephone: +41 41 79 92244

In-vitro diagnostics are a critical source of objective information helping doctors detect and diagnose diseases, select appropriate treatments and monitor patient response to care.
Making healthcare personal
In-vitro diagnostics helps doctors to understand that all patients are different and will have differing responses to a medicine. Personalised Healthcare (PHC) means targeting treatment to specific groups of patients who will respond best to those medicines. Rather than a ‘one-size-fits all' model, it is a tailored approach that incorporates the reality that people are different and so are the diseases that affect them.
This has enormous potential to make healthcare better, safer and more effective for patients, physicians, payers, and society at large.
Roche Diagnostics International Ltd
Centralised and Point of Care Solutions
Forrenstrasse 2

Knardrupvej 2
2760 Måløv
Phone: +45 4679 0247

ORIGIO is a world leader in Assisted Reproductive Technology (ART) solutions since 1987. Through research and innovation, ORIGIO aims at offering cutting-edge products and services to ART professionals during every step of the IVF process. Together with our customers, we help the #1 dream of every infertile couple come true.

ORIGIO employs approximately 400 people worldwide, is headquartered in Denmark, and markets its products in more than 100 countries.

ORIGIO is a CooperSurgical Company. Learn more at

PregLem is a Swiss-based specialty biopharmaceutical company dedicated to the development and commercialisation of innovative drugs for women's reproductive medicine. The company was founded in 2006 by Ernest Loumaye, a specialist in female reproductive medicine, and Eric Rolin, a finance executive in the pharmaceutical industry. PregLem's name reflects the company's goal of addressing unmet needs in gynaecology and infertility and its geographical location near Lake Geneva ("Lac Leman” in French).
PregLem is supported by a Scientific Advisory Board comprising the heads of reproductive medicine departments from major European academic institutions. PregLem's team expertise is in Clinical Product Development, Regulatory Affairs and Sales and Marketing of innovative products in women's health.
On 7th October 2010, Gedeon Richter Plc. announced the acquisition of PregLem SA and PregLem became a member of the Richter Group.
Gedeon Richter Plc., headquartered in Budapest/Hungary, is a major pharmaceutical company in Central Eastern Europe, with an expanding direct presence in Western Europe. Richter's consolidated sales were approximately EUR 1.1 billion (US$ 1.5 billion), while its market capitalization amounted to EUR 2.1 billion (US$ 2.5 billion) in 2014.
The product portfolio of Richter covers almost all important therapeutic areas, including gynaecology, central nervous system, and cardiovascular areas. Having the largest R&D unit in Central Eastern Europe, Richter's original research activity focuses on CNS disorders. With its widely acknowledged steroid chemistry expertise, Richter is a significant player in the female healthcare field worldwide. Richter is also active in biosimilar product development.

Parque Científico de Barcelona
Avda. Dr. Marañon 8
08028 Barcelona
Phone: +34 934 497 198
Fax: + 34 932 429 006

Embryotools is a company that has been founded by Gloria Calderón and Nuno Costa-Borges. Both hold an international reputation in the
IVF field with several remarks along their careers. While Gloria was a member of the team that obtained the first IVF babies in Spain, Nuno
carried out projects that led to the first successfully cloned animals in Spain and the first horses in Europe from biopsied embryos selected
for gender selection.
Located at Barcelona Scientific Park (PCB), Embryotools has state of the art laboratories equipped with the most advanced technology and equipment. The wide range of activities offered are organized in different centers that include: QC testing, IVF training and Consulting services.

Parc Científic Universitat de Valencia, C/Catedrático Agustín Escardino 9, 46980 Paterna (Valencia), Spain.
Tel: +34 963905310;
Fax: +34 963902522;

IGENOMIX is a company with broad experience in genetic and molecular diagnosis in Europe and one of the world references in these techniques. Igenomix's efforts in R&D enable the company to create and develop specific proprietary tools to support professionals in the reproductive medicine field.

Igenomix offers services such as PGS (Preimplantation Genetic Screening), PGD (Preimplantation Genetic Diagnosis), ERA (Endometrial Receptivity Array), POC (Products of Conception), CGT (Carrier Genetic Test) and NACE (Non-invasive Analysis for Chromosomal Examination).


Luis Buñuel 1 Acc, Pta 4
46015 Valencia
TL +34 963 050 978 Ext.
FX +34 963 232 880

IVICO in collaboration with the IVI Learning Center provides a number of services to
assisted reproduction units worldwide on theoretical knowledge, training and
business/lab consultancy. We work to give answer to all your needs in IVF and
for share all our know-how to achieve all your goals.

Kitazato is a Japanese Corporation involved in both the research and development of new devices in the IVF and ART fields and the manufacture of medical and biotechnological media for reproduction. Its wide product range includes Oocyte Retrieval Needles, Embryo Transfer Catheters, CRYOTOP®, Vitrification and Culture Media, Warm Plates and more.
Dibimed is Kitazato's exclusive distributor for Europe, Africa, Russia, and Latin America and it cooperates as well with some of the world's main IVF clinics organizing workshops where doctors and embryologists have the opportunity to learn everything about Kitazato products in order to improve their clinical results.
Kitazato Medical CO.Ltd. 1-1-8 Shibadaimon, Minato-ku. Tokyo 105-0012 JAPAN.
Tel +81-3-3434-2731 Fax +81-3-3434-2732 -
Dibimed Biomedical Supply S.L. Luis Buñuel1-Of.Pta.2.46015 Valencia, SPAIN.
Tel +34-963-056-395 Fax +34-963-056-396

Tel: +49 8765 93 99 00;
Fax: +49 8765 93 99 070;

MTG – your partner for turnkey projects, carrying the full range of lab equipment for ART. Our core products are:
-OCTAX NaviLase and Laser Shot lasers, Adaptive Electronic Condenser, cytoScreen dry IMSI, polarAIDE (spindle analysis)
-OCTAX Log & Guard (monitoring and alarming)
-OCTAX Ferti Proof (matching and tracking)
-pH Online (pH monitoring)
-medeaLAB CASA (sperm analysis)
-IncuCheck CO2 analyzer
-CTE freezers

OCTAX Microscience GmbH
Dr.-Pauling-Str. 9
D 84079 Bruckberg
+49 8765 9399042 t
+49 8765 9399070 f

OCTAX Microscience GmbH is a company with over 20 years' experience, developing high technology products used routinely in ART. The solutions are based on pioneering optoelectronic, mechanical and IT know how solving problems in ART applications being used worldwide for over 2 decades. OCTAX has developed several key solutions products like the IR laser Fertilase®, OCTAX Laser Shot and Navilase® for safe routine application in IVF. Apart from the most modern laser technologies, OCTAX Microscience GmbH has developed and built the only electronical condenser to optimize image quality from embryos and sperm beyond classical optical microscopes. OCTAX Microscience GmbH Company is also worldwide recognized for developing products for Quality Control and witnessing system dedicated to help embryologist working in the ART field.

Selva Nataraja PhD
Head of Biology, TocopheRx Inc
1500 District Avenue, Suite 1087
Burlington, MA 01803
Phone: 1-781-333-4088
Mobile: 1-781-724-6627
TocopheRx is an early stage biotech company dedicated to discovering and developing novel oral therapies for infertility treatment of women and men. Follicle stimulating hormone (FSH) currently used for treating infertility is administered by injection causing significant physical discomfort and increasing anxiety with each failed treatment cycle. TocopheRx is focused on developing novel orally active medicines that reduce the stress of infertility treatments. Our first disruptive innovation is an orally active, small molecule that stimulates the FSH receptor. Our preclinical results demonstrate that TOP001 offers a novel, effective, and convenient treatment for infertility, whether for female or male factor infertility.